Source: Eur Respir J 2006; 28: 1236-1244
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Birrell M. A., McCluskie K., Hardaker E., Knowles R., Belvisi M. G.. Utility of exhaled nitric oxide as a noninvasive biomarker of lung inflammation in a disease model. Eur Respir J 2006; 28: 1236-1244

Member's Comments

No comment yet.

Related content which might interest you: Exhaled nitric oxide in infants: a marker of inflammation? Source: Eur Respir Monogr 2010; 49: 56-70 Year: 2010 The source of exhaled nitric oxide does not correlate with clinical markers in interstitial lung disease Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease Year: 2007 Noninvasive assessment of airway inflammation in asthma Source: ISSN=1025-448x, ISBN=1-904097-26-x, page=164 Year: 2003 Exhaled nitric oxide (NO) detection for monitoring airway inflammation in non-severe CAP Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Bronchial and alveolar exhaled nitric oxide as a marker of systemic involvement in patients with Crohn‘s disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Screening with exhaled nitric oxide (ENO) may identify cases with on-going bronchial inflammation but not asthma symptoms Source: Eur Respir J 2001; 18: Suppl. 33, 38s Year: 2001 Sputum inflammatory biomarkers and exhaled nitric oxide (FENO) in varying severity asthmatics Source: Eur Respir J 2006; 28: Suppl. 50, 445s Year: 2006 Nitric oxide (NO) in exhaled breath helps to distinguish the origin of lung infiltrate Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens Year: 2012 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 Severity of scleroderma lung disease is related to alveolar concentration of nitric oxide Source: Eur Respir J 2007; 30: 26-30 Year: 2007 Clinically relevant early functional and diagnostic markers of lung disease in children Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=120 Year: 2006 Usefulness of fractional exhaled nitric oxide (FeNO) as a marker of asthma control Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Assessing inflammation non invasively: induced sputum, fractional exhaled nitric oxide concentration (FeNO), exhaled breath condensate (EBC) Source: Annual Congress 2006 - "Inflammometry": an alternative strategy in the management of airways disease Year: 2006 Exhaled nitric oxide as a biomarker in different COPD phenotypes Source: International Congress 2018 – Biomarkers for evaluating COPD Year: 2018 Fractional exhaled nitric oxide in chronic obstructive pulmonary disease Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice Source: Annual Congress 2013 –The multiple faces of stress in lung injury Year: 2013 Characterization of allergic airway inflammation in patients with COPD using fractional exhaled nitric oxide levels Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases Year: 2013 Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments Source: Eur Respir J 2009; 34: 117-124 Year: 2009 Exhaled nitric oxide is a useful marker of airway hyperreactivity in patients with chronic cough Source: Annual Congress 2005 - Experimental approaches to the study of chronic cough and cigarette smoking Year: 2005